18:19 IST
NSE
Management Change
SMS Pharmaceuticals Management Change
SMS Pharmaceuticals has re-appointed Mr. Ramesh Babu Potluri as Executive Director for a 60-month term effective October 1, 2026.
SMS Pharmaceuticals Ltd
- Share price
- ₹471.50
- Market cap
- ₹4,180 Cr
- Revenue (annual)
- ₹886.9 Cr
- Net profit (annual)
- ₹102.0 Cr
- P/E (TTM)
- 40.8×Sector 47.4×
- Promoter holding
- 68.07%+0.00% QoQ
- FII holding
- 0.65%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Legal & Regulatory 3Financial Results 3Earnings Call 3Results Update 2Other Announcement 2Board Meeting Date 2Annual General Meeting 2Price Movement Clarification 1Management Change 1Dividend 1Debt & Borrowing 1Credit Rating 1Capital Structure Change 1Board Meeting Outcome 1Annual Report 1
Time
1 announcement with these filters